glp 1 aspiration risk Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons | Dermatology and Therapy Filipino American Nurse Anesthesiology Society
Description
Join the Executive Network and enjoy unlimited content
GPR119, a major enteroendocrine sensor of dietary triglyceride metabolites coacting in synergy with FFA1 (GPR40) Endocrinology

For individuals on the obesity track and most of those with early-onset type 2 diabetes, BMI would be high enough that most of us would be comfortable prescribing these agents, but what about those with ASCVD
Skip anything that compounds gastric slowing or GI irritation: high-dose iron without a documented deficiency, large single doses of magnesium oxide, and stimulant "fat burners" stacked on a drug already suppressing appetite
Current management is based on case report outcomes and extrapolation from general neuropathic pain treatment

R., Fietze, I., Weaver, T
